SSY Group logo

SSY Group(SEHK) 2005

Market CapHK$8.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+1,225%
5 Year-28%
1 Year-4%
1 Month+4%
HK$2.75
+0.55%
+0.01Today
SSY Group last closing stock price
MetricPriceDate
Last closeHKD 2.752026-10-14
SSY Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.36%HKD 2.742026-10-07
1 month+3.77%HKD 2.652026-09-14
3 month+8.27%HKD 2.542026-07-16
Year to date-2.83%HKD 2.832025-12-31
1 year-3.51%HKD 2.852025-10-14
3 year-36.64%HKD 4.342023-10-13
5 year-27.82%HKD 3.812021-10-15
Since inception+1,224.62%HKD 0.212005-12-20

SSY Group Financials at a Glance

Market Cap

HK$8.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$8.96B

Net Income (TTM)

HK$1.17B

EPS (TTM)

HK$0.17

P/E Ratio

15.68

Dividend

HK$0.09

Beta (Volatility)

0.04 (Low)

Price

HK$2.75

Volume

8,402,000

Open

HK$2.72

Previous Close

HK$2.73

Daily Range

HK$2.69 - HK$2.77

52-Week Range

HK$2.01 - HK$3.18

Estimated Earnings Date

Mar 26, 2027

2005 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SSY Group

SSY Group Limited is a prominent player in the pharmaceutical industry, focusing on the research, development, manufacturing, and distribution of a wide range of medical products. The company primarily serves hospitals and distributors in China and internationally, offering innovative intravenous infusion solutions and various pharmaceutical preparations.

Products and Services
  • Intravenous infusion solutions, including non-PVC and soft bag options
  • Small volume injections and oral preparations
  • Research and consulting services in pharmaceutical technology
Growth Outlook
  • Revenue of HKD 2.36 billion in Q2 2026, showing strong demand
  • Net income increased to HKD 320 million in Q2 2026, reflecting profitability
  • Operating income margin improved to 16.5% in Q2 2026, indicating operational efficiency
Financial Highlights
  • Trailing twelve-month revenue of HKD 9.1 billion, demonstrating consistent growth
  • Dividend yield of 3.20%, providing attractive returns to shareholders
  • Net profit margin of 11.6% for the trailing twelve months, showcasing financial health
SSY Group Limited has established itself as a key player in the healthcare sector, with a diverse product portfolio that caters to various medical needs. The company's focus on innovation and quality has positioned it well for future growth, particularly in the rapidly expanding pharmaceutical market in China. Recent financial performance indicates a robust upward trajectory, with significant revenue and profit growth in the latest quarter. The company's commitment to operational efficiency and strategic investments in research and development further enhance its competitive edge. With a solid dividend yield, SSY Group Limited presents an appealing opportunity for investors looking to engage with a dynamic and growing pharmaceutical company.
AI Generated • Oct 12, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,500

CEO

Ji Guang Qu

Website

www.ssygroup.com.hk

Headquarters

Hong Kong, 200021, HK

2005 Financials

Key Financial Metrics (TTM)

Gross Margin

40.03%

Operating Margin

14.79%

Net Income Margin

11.59%

Return on Equity

6.72%

Return on Capital

5.56%

Return on Assets

3.77%

Earnings Yield

6.38%

Dividend Yield

3.11%

Payout Ratio

46.03%

Stock Overview

Market Cap

HK$8.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.95B

Volume

8.40M

Avg. Volume

4.12M

Financials (TTM)

Gross Profit

HK$3.71B

Operating Income

HK$1.51B

EBITDA

HK$2.38B

Operating Cash Flow

HK$1.35B

Capital Expenditure

-HK$356.99M

Free Cash Flow

HK$992.68M

Cash & ST Invst.

HK$1.97B

Total Debt

HK$4.05B

SSY Group Performance Analysis

SSY Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 6,434,025,00020.1%
20232023-12-31HKD 6,463,009,0000.5%
20242024-12-31HKD 5,773,251,000-10.7%
20252025-12-31HKD 4,165,465,000-27.8%
SSY Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-27.1%
Q22025-06-30-11.8%
Q42025-12-31-6.0%
Q22026-06-3017.0%
SSY Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD 0.3845.2%
20232023-12-31HKD 0.4417.7%
20242024-12-31HKD 0.36-19.1%
20252025-12-31HKD 0.16-55.2%
SSY Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-43.5%
Q22025-06-30-26.0%
Q42025-12-31-33.4%
Q22026-06-3071.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

HK$2.36B

-29.3%

Gross Profit

HK$912.08M

-50.5%

Gross Margin

38.64%

N/A

Market Cap

HK$8.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$1.49M

N/A

Employees

5,400

N/A

Net Income

HK$320.32M

-53.3%

EBITDA

HK$618.55M

-43.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

HK$1.97B

+22.9%

Total Debt

HK$4.05B

+12.1%

Accounts Receivable

HK$1.81B

-18.5%

Inventory

HK$1.24B

+8.5%

Long Term Debt

HK$2.19B

-19.3%

Short Term Debt

HK$1.86B

+107.4%

Return on Assets

3.77%

N/A

Return on Invested Capital

6.08%

N/A

Free Cash Flow

HK$396.71M

+175.6%

Operating Cash Flow

HK$525.96M

+62.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
BACBank of America
$51.39-4.76%
NVDANvidia
$221.30-3.16%
CRWVCoreWeave
$65.78-15.46%
INTCIntel
$98.12-4.56%

Questions About 2005

What is the current price of SSY Group?

SSY Group is trading at HK$2.75 per share.

What is the 52-week range for SSY Group?

Over the past 52 weeks, SSY Group has traded between HK$2.01 and HK$3.18.

How much debt does SSY Group have?

As of the most recent reporting period, SSY Group reported total debt of HK$4.01B.

How much cash does SSY Group have on hand?

SSY Group reported HK$1.71B in cash and cash equivalents in its most recent financial results.

What is SSY Group’s dividend yield?

SSY Group currently has a dividend yield of 3.11%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services